Story
AbCellera Stock Falls 3.7% After Announcing $200 Million Public Offering

AbCellera Biologics Inc. (NASDAQ:ABCL) shares fell 3.7% in after-hours trading Tuesday after the company announced a proposed $200 million underwritten public offering. The stock's decline reflects investor reaction to the potential for shareholder dilution from the issuance of new equity.
Details of the Offering
According to the company's statement, the offering will consist of common shares and pre-funded warrants to purchase common shares, which will be offered in lieu of common stock to certain investors. AbCellera confirmed that it is the sole entity offering the securities.
The company cautioned that the offering is subject to market conditions and other factors. There is no assurance as to whether or when the offering may be completed, nor can the final size or terms be guaranteed at this time.
Use of Proceeds and Market Impact
AbCellera intends to use the net proceeds to bolster its financial position and advance its pipeline. The funds are specifically earmarked for:
Ad- Continued research and development activities.
- The clinical advancement of its internal programs, including its lead candidate, ABCL635.
- General working capital and other corporate purposes.
The drop in share price is a typical market response to secondary offerings. By increasing the number of shares outstanding, such capital raises dilute the ownership percentage of existing shareholders, which often places immediate downward pressure on the stock price.
Underwriters and Company Focus
A consortium of investment banks is managing the proposed offering. Jefferies, J.P. Morgan, Cantor, UBS Investment Bank, and BMO Capital Markets are serving as the joint book-running managers for the deal.
AbCellera is a clinical-stage biotechnology firm that focuses on discovering and developing antibody-based medicines for therapeutic areas including endocrinology, women’s health, immunology, and oncology.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.